e-Drug3D 1224 |
MESORIDAZINE DISCONTINUED
|
cas 5588-33-0 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL INJECTION |
ATC code |
PK parameters |
Target TARGET D(2) DOPAMINE RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file | 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine Formula: Calculated chemical properties: MW 386.58 NB_atoms 26 XLogP 4.90 PSA 24.701 NB_HD 0 NB_HA 3 fsp3 0.43 Lipinski(0=no;1=yes) 1 |
FDA NDA 016774 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1970 DISCONTINUED NDA 016775 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1970 DISCONTINUED NDA 016997 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1972 DISCONTINUED |
Other links: |